Baron Wealth Management’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-16,239
Closed -$136K – 313
2026
Q2
$136K Buy
16,239
+1,119
+7% +$9.36K 0.04% 299
2026
Q1
$125K Buy
15,120
+4,335
+40% +$44.9K 0.04% 275
2025
Q4
$133K Buy
+10,785
New +$116K 0.04% 246

Other funds holding EBS

Baron Wealth Management's EBS Position: Q3 2026 in Review

Baron Wealth Management sold out of Emergent Biosolutions (EBS) in Q3 2026, closing a stake of 16,239 shares — an estimated $136K sold.

Baron Wealth Management first reported a position in EBS in Q4 2025 and held it in 3 quarters. The position peaked at $136K in Q2 2026. 187 funds tracked by Wall St. Rank hold EBS as of Q3 2026.

  • Baron Wealth Management reported no remaining Emergent Biosolutions position as of Q3 2026 after selling out during the quarter.
  • Baron Wealth Management sold 16,239 Emergent Biosolutions shares in Q3 2026, an estimated $136K.
  • Baron Wealth Management first reported a position in Emergent Biosolutions in Q4 2025 and held it in 3 quarters.
  • Baron Wealth Management's Emergent Biosolutions position peaked at $136K in Q2 2026.
  • 187 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2026.

Based on Baron Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.